| 标题 |
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet (London, England) 作者:Fisher BA; Mariette X; Papas A; Grader-Beck T; Bootsma H; et al 出版日期:2024/08/10 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)